A detailed history of Td Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Td Asset Management Inc holds 1,762,956 shares of JNJ stock, worth $257 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,762,956
Previous 1,658,398 6.3%
Holding current value
$257 Million
Previous $242 Million 17.87%
% of portfolio
0.27%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$145.48 - $167.38 $15.2 Million - $17.5 Million
104,558 Added 6.3%
1,762,956 $286 Million
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $7.33 Million - $8.01 Million
50,797 Added 3.16%
1,658,398 $242 Million
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $537,992 - $564,056
3,466 Added 0.22%
1,607,601 $254 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $11.1 Million - $12.1 Million
-76,452 Reduced 4.55%
1,604,135 $251 Million
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $14.9 Million - $16.6 Million
-95,425 Reduced 5.37%
1,680,587 $262 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $8.92 Million - $9.6 Million
-57,777 Reduced 3.15%
1,776,012 $294 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $206 Million - $246 Million
-1,363,498 Reduced 42.65%
1,833,789 $284 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $6.05 Million - $6.79 Million
-37,774 Reduced 1.17%
3,197,287 $565 Million
Q3 2022

Nov 07, 2022

BUY
$161.33 - $179.52 $2.25 Million - $2.5 Million
13,940 Added 0.43%
3,235,061 $532 Million
Q2 2022

Aug 04, 2022

SELL
$168.19 - $186.01 $7.36 Million - $8.14 Million
-43,760 Reduced 1.34%
3,221,121 $572 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $33.5 Million - $38.1 Million
212,070 Added 6.95%
3,264,881 $579 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $236,545 - $262,456
-1,517 Reduced 0.05%
3,052,811 $522 Million
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $6.07 Million - $6.75 Million
-37,600 Reduced 1.22%
3,054,328 $493 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $27.8 Million - $29.9 Million
174,594 Added 5.98%
3,091,928 $532 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $7.45 Million - $8.29 Million
-48,652 Reduced 1.64%
2,917,334 $479 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $19.8 Million - $22.8 Million
-144,568 Reduced 4.65%
2,965,986 $467 Million
Q3 2020

Nov 10, 2020

SELL
$140.38 - $153.83 $63.6 Million - $69.7 Million
-453,073 Reduced 12.71%
3,110,554 $463 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $37.5 Million - $45.2 Million
290,895 Added 8.89%
3,563,627 $501 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $52.7 Million - $73 Million
474,367 Added 16.95%
3,272,732 $429 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $20.1 Million - $23.1 Million
157,545 Added 5.97%
2,798,365 $408 Million
Q3 2019

Nov 07, 2019

BUY
$126.95 - $142.14 $11.8 Million - $13.2 Million
92,946 Added 3.65%
2,640,820 $342 Million
Q2 2019

Aug 01, 2019

BUY
$131.15 - $144.24 $4.2 Million - $4.62 Million
32,007 Added 1.27%
2,547,874 $355 Million
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $3.2 Million - $3.56 Million
25,449 Added 1.02%
2,515,867 $352 Million
Q4 2018

Feb 01, 2019

SELL
$122.84 - $147.84 $1.15 Million - $1.38 Million
-9,365 Reduced 0.37%
2,490,418 $321 Million
Q3 2018

Nov 01, 2018

SELL
$121.58 - $142.88 $29.8 Million - $35 Million
-245,157 Reduced 8.93%
2,499,783 $345 Million
Q2 2018

Jul 31, 2018

SELL
$119.4 - $131.76 $22.5 Million - $24.8 Million
-188,397 Reduced 6.42%
2,744,940 $333 Million
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $21.5 Million - $25.5 Million
-172,099 Reduced 5.54%
2,933,337 $376 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $2.26 Million - $2.47 Million
-17,204 Reduced 0.55%
3,105,436 $434 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $404 Million - $423 Million
3,122,640
3,122,640 $406 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.